Cargando…

Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis

BACKGROUND: Interferon-beta (IFNβ) is used to inhibit disease activity in multiple sclerosis (MS), but its mechanisms of action are incompletely understood, individual treatment response varies, and biological markers predicting response to treatment have yet to be identified. METHODS: The relations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudick, Richard A., Rani, M. R. Sandhya, Xu, Yaomin, Lee, Jar-Chi, Na, Jie, Shrock, Jennifer, Josyula, Anupama, Fisher, Elizabeth, Ransohoff, Richard M.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094352/ https://www.ncbi.nlm.nih.gov/pubmed/21602934 http://dx.doi.org/10.1371/journal.pone.0019262

Ejemplares similares

Chemokine Receptors as Biomarkers in Multiple Sclerosis
por: Fox, Robert J., et al.
Publicado: (2006)

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
por: Rudick, Richard A., et al.
Publicado: (2014)

Measuring treatment response to advance precision medicine for multiple sclerosis
por: Calabresi, Peter A., et al.
Publicado: (2021)

Animal models of multiple sclerosis: the good, the bad and the bottom line
por: Ransohoff, Richard M
Publicado: (2012)

Natalizumab for the treatment of relapsing multiple sclerosis
por: Rudick, Richard A, et al.
Publicado: (2008)

Cytokines as Biomarkers of Treatment Response to IFNβ in Relapsing-Remitting Multiple Sclerosis
por: Dimisianos, Nikolaos, et al.
Publicado: (2014)

IFN-γ protects from lethal IL-17 mediated viral encephalomyelitis independent of neutrophils
por: Savarin, Carine, et al.
Publicado: (2012)

Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
por: Aliaga-Gaspar, Pablo, et al.
Publicado: (2021)

Excessively increased thalamocortical connectivity and poor initial antiseizure medication response in epilepsy patients
por: Zhong, Jiyuan, et al.
Publicado: (2023)

Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy
por: Mehling, Matthias, et al.
Publicado: (2013)

The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis
por: Mariotti, Barbara, et al.
Publicado: (2019)

Regulation of class II major histocompatibility complex genes: Relation to multiple sclerosis
por: Ransohoff, R.M.
Publicado: (1989)

No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis
por: Campbell, Graham R, et al.
Publicado: (2013)

Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-β
por: Muñoz, Úrsula, et al.
Publicado: (2022)

Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses
por: Béland, Louis-Charles, et al.
Publicado: (2020)

Dysregulation of IFN System Can Lead to Poor Response to Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis C
por: Onomoto, Koji, et al.
Publicado: (2011)

Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability
por: Brier, Matthew R., et al.
Publicado: (2021)

Optineurin Negatively Regulates the Induction of IFNβ in Response to RNA Virus Infection
por: Mankouri, Jamel, et al.
Publicado: (2010)

Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2019)

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
por: Benedict, Ralph HB, et al.
Publicado: (2017)

IFN-Aging: Coupling Aging With Interferon Response
por: Cao, Wei
Publicado: (2022)

Conserved and tissue-specific immune responses to biologic scaffold implantation
por: DeStefano, Sabrina, et al.
Publicado: (2023)

IFN-γ fails to overcome inhibition of selected macrophage activation events in response to pathogenic mycobacteria
por: Thirunavukkarasu, Shyamala, et al.
Publicado: (2017)

Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases
por: de Jong, Tamarah D., et al.
Publicado: (2016)

Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
por: Motl, Robert W, et al.
Publicado: (2017)

The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
por: Feys, Peter, et al.
Publicado: (2017)

Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets
por: Thoutam, Akshaya, et al.
Publicado: (2020)

A meditation on medications, among other things
por: Ransohoff, Richard M.
Publicado: (2014)

Gathering thunder
por: Ransohoff, Richard M.
Publicado: (2014)

Informing and inspiring
por: Ransohoff, Richard M.
Publicado: (2014)

Meet the new team!
por: Ransohoff, Richard M.
Publicado: (2014)

All (animal) models (of neurodegeneration) are wrong. Are they also useful?
por: Ransohoff, Richard M.
Publicado: (2018)

Digital dermatitis in cattle is associated with an excessive innate immune response triggered by the keratinocytes
por: Refaai, Walid, et al.
Publicado: (2013)

Poor Responses to Interferon-Beta Treatment in Patients with Neuromyelitis Optica and Multiple Sclerosis with Long Spinal Cord Lesions
por: Wang, Kai-Chen, et al.
Publicado: (2014)

IFN type III: in vivo NK cell response
por: Souza-Fonseca-Guimaraes, Fernando, et al.
Publicado: (2015)

The Interplay Between Coronavirus and Type I IFN Response
por: Xue, Wenxiang, et al.
Publicado: (2022)

Excessive production and extreme editing of human metapneumovirus defective interfering RNA is associated with type I IFN induction
por: van den Hoogen, Bernadette G., et al.
Publicado: (2014)

The excessive response: a preparation for harder conditions
por: Ren, Yaguang, et al.
Publicado: (2017)

In Vivo IFN-γ Secretion by NK Cells in Response to Salmonella Typhimurium Requires NLRC4 Inflammasomes
por: Kupz, Andreas, et al.
Publicado: (2014)

Characterization of Polyethylene Using a New Test Method Based on Stress Response to Relaxation and Recovery
por: Shi, Furui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_748oh8ot8geruidl4qd5g8q7be